Omeprazole Teva

Omeprazole, the active ingredient in Omeprazole Teva, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults. GNH USA supplies Omeprazole Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole Teva is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related gastrointestinal conditions: - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the oesophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces the risk of recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with this rare endocrine disorder.

Adverse reactions to omeprazole are generally mild to moderate and vary with duration of therapy.

Common Side Effects: - Headache: mild, transient headache reported by some patients. - Diarrhoea: loose stools occurring during early treatment. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach region. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis linked to altered gut flora. - Acute interstitial nephritis: sudden kidney inflammation. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Low magnesium levels: muscle cramps, irregular heartbeat, or seizures. - Fracture risk: increased incidence of hip, wrist or spine fractures with long‑term use.

When prescribing Omeprazole Teva, clinicians should consider several safety aspects: - Assess patient history for renal or hepatic impairment: dosage adjustments may be required. - Review the presence of CYP enzyme inhibitors or inducers that may affect drug levels. - Monitor for signs of vitamin B12 deficiency during long‑term therapy.\n- Advise patients to report any persistent gastro‑gastro of the the g g g g. - Store at below 25°C: keep in the original pack of the … … … ... ... ... ... ... ... ... … … … … … … ... … ... … … … -  -  -  -  -  -  -  - ullet  ...